Litigation Details for Value Drug Company v. Endo Health Solutions, Inc. (N.D. Ill. 2014)
✉ Email this page to a colleague
Value Drug Company v. Endo Health Solutions, Inc. (N.D. Ill. 2014)
Docket | ⤷ Try a Trial | Date Filed | 2014-07-16 |
Court | District Court, N.D. Illinois | Date Terminated | |
Cause | 15:1 Antitrust Litigation | Assigned To | Harry Daniel Leinenweber |
Jury Demand | Plaintiff | Referred To | |
Patents | 7,276,250 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Value Drug Company v. Endo Health Solutions, Inc.
Details for Value Drug Company v. Endo Health Solutions, Inc. (N.D. Ill. 2014)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2014-07-16 | 1 | what ultimately issued as United States Patent No. 7,276,250 entitled sustained release formulations …, and ‘933 patents as well as any continuations of those patents and to any pending patent applications…that is, while the patent litigation was still pending); or (b) after winning the patent suit; or (c) via… normal patent infringement litigation settlements, the alleged infringer would pay the patent holder.… the manufacturer’s patents for accuracy or trustworthiness. In listing patents in the Orange Book, | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |